Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly effective, and convenient once-daily oral JAK ...

U.S. Food and Drug Administration approves Zenrelia, a once-daily oral JAK inhibitor for dogs with allergic and atopic ...

Immune-complex vaccines will ensure long-term protection.

ZTS' innovative pet care products, along with efforts to expand the business, are expected to fuel significant growth in the future.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

After hours: September 17 at 7:43 PM EDT Loading Chart for ZTS ...

Zoetis, announced it will introduce a new diagnostic tool Vetscan OptiCell, a hematology analyzer that is cartridge-based and artificial intelligence powered that can get a more advanced Complete ...

Analyst Glen Santangelo of Jefferies reiterated a Buy rating on Bausch Health Companies (BHC – Research Report), reducing the price ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

As of September 10, 2024, Zoetis Inc had a $86.9 billion market capitalization, putting it in the 98th percentile of companies in the Pharmaceuticals industry. Currently, Zoetis Inc’s price-earnings ...